23andMe Holding Co Class A ME
Find similar stocks with Morningstar Investor.
Morningstar analysts do not currently cover ME, but with our powerful screener, you can find
stocks in the same sector,industry, or style and filter on our unbiased ratings and valuation metrics.
News
-
ME INVESTOR NOTICE: Current 23andMe Holding Co. Shareholders are Notified to Contact BFA Law about Investigation into the Board of Directors (Nasdaq:ME)
-
ME INVESTOR UPDATE: Shareholders of 23andMe Holding Co. are Alerted of Pending Investigation into the Company; Contact BFA Law if You Own Substantial Shares (Nasdaq:ME)
-
ME INVESTIGATION NOTICE: The Investigation into 23andMe Holding Co. is Ongoing – Contact BFA Law if You are a Current Shareholder (Nasdaq:ME)
-
23andMe Launches New Genetic Report on Likelihood of Frequent Emotional Eating
-
ME SHAREHOLDER UPDATE: 23andMe Holding Co. is Under Investigation for Breaches of Fiduciary Duties; Current Shareholders are Urged to Contact BFA Law (Nasdaq:ME)
-
Barrack, Rodos & Bacine Is Investigating 23andMe Holding Co.
-
Barrack, Rodos & Bacine Is Investigating 23andMe Holding Co.
-
ME INVESTIGATION NOTICE: 23andMe Holding Co.’s Board of Directors is Being Investigated; Current Shareholders are Urged to Contact BFA Law (Nasdaq:ME)
Trading Information
- Previous Close Price
- $0.39
- Day Range
- $0.27–0.39
- 52-Week Range
- $0.27–1.02
- Bid/Ask
- $0.30 / $0.30
- Market Cap
- $149.17 Mil
- Volume/Avg
- 11.2 Mil / 3.0 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.72
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 582
- Website
- https://www.23andme.com
Comparables
Valuation
|
Metric
|
ME
|
GRAL
|
688468
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 21.05 |
Price/Book Value | 1.04 | 0.15 | 2.05 |
Price/Sales | 0.72 | 3.69 | 6.16 |
Price/Cash Flow | — | — | 14.42 |
Price/Earnings
ME
GRAL
688468
Financial Strength
|
Metric
|
ME
|
GRAL
|
688468
|
|---|---|---|---|
Quick Ratio | 1.29 | 11.09 | 4.71 |
Current Ratio | 1.52 | 11.55 | 5.48 |
Interest Coverage | — | — | 111.54 |
Quick Ratio
ME
GRAL
688468
Profitability
|
Metric
|
ME
|
GRAL
|
688468
|
|---|---|---|---|
Return on Assets (Normalized) | −33.64% | −11.72% | 7.46% |
Return on Equity (Normalized) | −50.95% | −13.53% | 9.59% |
Return on Invested Capital (Normalized) | −44.67% | −13.47% | 7.98% |
Return on Assets
ME
GRAL
688468
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| Jbgmnpvy | Vlk | $228.7 Bil | |||
| Danaher Corp
DHR
| Yfvvmymwr | Tpgjxx | $195.0 Bil | |||
| IQVIA Holdings Inc
IQV
| Svclzlm | Qfrgz | $41.9 Bil | |||
| Agilent Technologies Inc
A
| Mchrkyjvyr | Mlbp | $41.7 Bil | |||
| IDEXX Laboratories Inc
IDXX
| Rdzcbyfvd | Zdyk | $39.3 Bil | |||
| Mettler-Toledo International Inc
MTD
| Mpdgnbxy | Vkcnw | $30.8 Bil | |||
| Icon PLC
ICLR
| Ppxdwbsz | Hrdcms | $24.3 Bil | |||
| Illumina Inc
ILMN
| Txzsydlv | Wnxtpfk | $22.5 Bil | |||
| Waters Corp
WAT
| Slpkrkdjhz | Lhmj | $20.9 Bil | |||
| Labcorp Holdings Inc
LH
| Lpfwztznh | Lftjd | $18.1 Bil |
United States